Peter U. Park

NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER

#2 | 2025-02-27

US20250066489A1

MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF

#3 | 2023-08-24

US20230265197A1

MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF

#4 | 2021-09-30

US20210301031A1

NAPI2B-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF

#5 | 2020-12-31

US20200408765A1

NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER

#6 | 2020-08-27

US20200270361A1

CD37-BINDING MOLECULES AND IMMUNOCONJUGATES THEREOF

#7 | 2020-01-30

US20200031941A1

Monoclonal antibodies against HER2 epitope and methods of use thereof

#8 | 2018-08-16

US20180230218A1

MET ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREOF

#9 | 2017-11-30

US20170343550A1

NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER

#10 | 2017-11-02

US20170313778A1

MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF

#11 | 2017-03-09

US20170066830A1

Monoclonal antibodies against HER2 epitope and methods of use thereof

#12 | 2016-11-24

US20160340438A1

CD37-binding molecules and immunoconjugates thereof

#13 | 2016-04-28

US20160115238A1

CD20 Antibodies and Uses Thereof

#14 | 2016-04-21

US20160108126A1

CD20 Antibodies and Uses Thereof

#15 | 2016-03-03

US20160060345A1

Novel EGFR-Binding Molecules and Immunoconjugates Thereof

#16 | 2016-01-21

US20160017053A1

Non-Antagonistic EGFR-Binding Molecules and Immunoconjugates Thereof

#17 | 2015-12-24

US20150366987A1

Monoclonal antibodies against HER2 epitope and methods of use thereof

#18 | 2015-12-24

US20150366982A1

Protein-polymer-drug conjugates and methods of using same

#19 | 2014-04-10

US20140099308A1

EGFR-binding molecules and immunoconjugates thereof

#20 | 2014-01-23

US20140023662A1

Non-antagonistic EGFR-binding molecules and immunoconjugates thereof

#21 | 2013-06-20

US20130156796A1

Method of treatment of tumors that are resistant to EGFR antibody therapies by EGFR antibody cytotoxic agent conjugate

#22 | 2012-11-01

US20120276119A1

CD37-binding molecules and immunoconjugates thereof

#23 | 2012-06-21

US20120156218A1

NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER

#24 | 2012-06-21

US20120156217A1

EGFR-binding molecules and immunoconjugates thereof

#25 | 2011-10-27

US20110262454A1

NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER

#26 | 2011-08-11

US20110195022A1

CD20 antibodies and uses thereof

#27 | 2011-08-11

US20110195021A1

CD20 antibodies and uses thereof

#28 | 2009-12-10

US20090304710A1